most of those receiving cyclosporine ( csa ) prophylaxis ( 7/9 ) developed hla-dr- gvhd , while those receiving cyclophosphamide were split between the two groups ( 8 of 13 were hla-dr+ ) .
C0010592
cyclosporine
C0018133
gvhd